Skip to main content
. 2021 Jun 11;4(6):e2111788. doi: 10.1001/jamanetworkopen.2021.11788

Figure 4. Mortality Over Time by Anticoagulant Exposure.

Figure 4.

Each patient was weighted by the inverse probability of being in their anticoagulant exposure group. Compared with no anticoagulation, only prophylactic-dose anticoagulation was associated with lower mortality at 60 days (prophylactic dose: aHR, 0.706; 95% CI, 0.514-0.897; treatment dose: aHR, 0.922; 95% CI, 0.631-1.348).